Members |
associationTargetComponent |
Aczicrit 9000 units/0.9 mL injection solution, 6 x 0.9 mL syringes |
Unknown Cell Type 2 |
Adacel (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 0.5 mL vial (trade product unit of use) |
Unknown Cell Type 2 |
Adacel (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 1 x 0.5 mL vial (containered trade product pack) |
Unknown Cell Type 2 |
Adacel (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 1 x 0.5 mL vial (trade product pack) |
Unknown Cell Type 2 |
Adacel (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 5 x 0.5 mL vials (containered trade product pack) |
Unknown Cell Type 2 |
Adacel (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 5 x 0.5 mL vials (trade product pack) |
Unknown Cell Type 2 |
Adacel injection suspension, 0.5 mL vial |
Adacel injection, 0.5 mL vial |
Adacel injection suspension, 0.5 mL vial |
Adacel injection, 0.5 mL vial |
Adacel injection suspension, 0.5 mL vial |
Adacel injection, 0.5 mL vial |
Adacel injection suspension, 5 x 0.5 mL vials |
Adacel injection, 5 x 0.5 mL vials |
Adacel injection suspension, 5 x 0.5 mL vials |
Adacel injection, 5 x 0.5 mL vials |
Adacel Polio (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection suspension, 0.5 mL syringe (trade product unit of use) |
Unknown Cell Type 2 |
Adacel Polio (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection suspension, 0.5 mL vial (trade product unit of use) |
Unknown Cell Type 2 |
Adacel Polio (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection suspension, 1 x 0.5 mL syringe (containered trade product pack) |
Unknown Cell Type 2 |
Adacel Polio (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection suspension, 1 x 0.5 mL syringe (trade product pack) |
Unknown Cell Type 2 |
Adacel Polio (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection suspension, 1 x 0.5 mL vial (containered trade product pack) |
Unknown Cell Type 2 |
Adacel Polio (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection suspension, 1 x 0.5 mL vial (trade product pack) |
Unknown Cell Type 2 |
Adacel Polio (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection suspension, 5 x 0.5 mL syringes (containered trade product pack) |
Unknown Cell Type 2 |
Adacel Polio (Bordetella pertussis filamentous haemagglutinin antigen 5 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 2.5 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection suspension, 5 x 0.5 mL syringes (trade product pack) |
Unknown Cell Type 2 |
Adacel Polio injection suspension, 0.5 mL syringe |
Adacel Polio injection, 0.5 mL syringe |
Adacel Polio injection suspension, 0.5 mL vial |
Adacel Polio injection, 0.5 mL vial |
Adacel Polio injection suspension, 0.5 mL syringe |
Adacel Polio injection, 0.5 mL syringe |
Adacel Polio injection suspension, 0.5 mL syringe |
Adacel Polio injection, 0.5 mL syringe |
Adacel Polio injection suspension, 0.5 mL vial |
Adacel Polio injection, 0.5 mL vial |
Adacel Polio injection suspension, 0.5 mL vial |
Adacel Polio injection, 0.5 mL vial |
Adacel Polio injection suspension, 5 x 0.5 mL syringes |
Adacel Polio injection, 5 x 0.5 mL syringes |
Adacel Polio injection suspension, 5 x 0.5 mL syringes |
Adacel Polio injection, 5 x 0.5 mL syringes |
Adacel Polio injection suspension, 0.5 mL syringe |
Unknown Cell Type 2 |
Adacel Polio injection suspension, 0.5 mL syringe |
Unknown Cell Type 2 |
Adacel Polio injection suspension, 0.5 mL syringe |
Unknown Cell Type 2 |
Adacel Polio injection suspension, 0.5 mL vial |
Unknown Cell Type 2 |
Adacel Polio injection suspension, 0.5 mL vial |
Unknown Cell Type 2 |
Adacel Polio injection suspension, 0.5 mL vial |
Unknown Cell Type 2 |
Adacel Polio injection suspension, 5 x 0.5 mL syringes |
Unknown Cell Type 2 |
Adacel Polio injection suspension, 5 x 0.5 mL syringes |
Unknown Cell Type 2 |
Adacel injection suspension, 0.5 mL vial |
Unknown Cell Type 2 |
Adacel injection suspension, 0.5 mL vial |
Unknown Cell Type 2 |
Adacel injection suspension, 0.5 mL vial |
Unknown Cell Type 2 |
Adacel injection suspension, 5 x 0.5 mL vials |
Unknown Cell Type 2 |
Adacel injection suspension, 5 x 0.5 mL vials |
Unknown Cell Type 2 |
Adalat (nifedipine 10 mg) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Adalat (nifedipine 10 mg) film-coated tablet, 60 tablets (trade product pack) |
Unknown Cell Type 2 |
Adalat (nifedipine 10 mg) film-coated tablet, 60 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adalat (nifedipine 20 mg) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Adalat (nifedipine 20 mg) film-coated tablet, 60 tablets (trade product pack) |
Unknown Cell Type 2 |
Adalat (nifedipine 20 mg) film-coated tablet, 60 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adalat 10 mg film-coated tablet |
Unknown Cell Type 2 |
Adalat 10 mg film-coated tablet, 60 |
Unknown Cell Type 2 |
Adalat 10 mg film-coated tablet, 60, blister pack |
Unknown Cell Type 2 |
Adalat 20 mg film-coated tablet |
Unknown Cell Type 2 |
Adalat 20 mg film-coated tablet, 60 |
Unknown Cell Type 2 |
Adalat 20 mg film-coated tablet, 60, blister pack |
Unknown Cell Type 2 |
Addaven (chromic chloride hexahydrate 53.33 microgram / 10 mL + cupric chloride dihydrate 1.02 mg / 10 mL + ferric chloride hexahydrate 5.4 mg / 10 mL + manganese chloride tetrahydrate 198 microgram / 10 mL + potassium iodide 166 microgram / 10 mL + sodium fluoride 2.1 mg / 10 mL + sodium molybdate dihydrate 48.5 microgram / 10 mL + sodium selenite 173 microgram / 10 mL + zinc chloride 10.5 mg / 10 mL) concentrated injection, 10 mL ampoule (trade product unit of use) |
Unknown Cell Type 2 |
Addaven (chromic chloride hexahydrate 53.33 microgram / 10 mL + cupric chloride dihydrate 1.02 mg / 10 mL + ferric chloride hexahydrate 5.4 mg / 10 mL + manganese chloride tetrahydrate 198 microgram / 10 mL + potassium iodide 166 microgram / 10 mL + sodium fluoride 2.1 mg / 10 mL + sodium molybdate dihydrate 48.5 microgram / 10 mL + sodium selenite 173 microgram / 10 mL + zinc chloride 10.5 mg / 10 mL) concentrated injection, 20 x 10 mL ampoules (containered trade product pack) |
Unknown Cell Type 2 |
Addaven (chromic chloride hexahydrate 53.33 microgram / 10 mL + cupric chloride dihydrate 1.02 mg / 10 mL + ferric chloride hexahydrate 5.4 mg / 10 mL + manganese chloride tetrahydrate 198 microgram / 10 mL + potassium iodide 166 microgram / 10 mL + sodium fluoride 2.1 mg / 10 mL + sodium molybdate dihydrate 48.5 microgram / 10 mL + sodium selenite 173 microgram / 10 mL + zinc chloride 10.5 mg / 10 mL) concentrated injection, 20 x 10 mL ampoules (trade product pack) |
Unknown Cell Type 2 |
Addaven concentrated injection, 10 mL ampoule |
Unknown Cell Type 2 |
Addaven concentrated injection, 20 x 10 mL ampoules |
Unknown Cell Type 2 |
Addaven concentrated injection, 20 x 10 mL ampoules |
Unknown Cell Type 2 |
Addiction |
Addiction |
Addison's disease, NOS |
Addison's disease |
Additional preoperative procedure instituted by anaesthetist |
Preoperative procedure |
Additional preoperative therapy instituted by anaesthetist |
Preoperative procedure |
Adductor digiti minimi muscle of hand |
Structure of abductor digiti minimi muscle of hand |
Adefin (nifedipine 10 mg) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Adefin (nifedipine 10 mg) film-coated tablet, 60 tablets (trade product pack) |
Unknown Cell Type 2 |
Adefin (nifedipine 10 mg) film-coated tablet, 60 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adefin (nifedipine 20 mg) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Adefin (nifedipine 20 mg) film-coated tablet, 60 tablets (trade product pack) |
Unknown Cell Type 2 |
Adefin (nifedipine 20 mg) film-coated tablet, 60 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adefin 10 mg film-coated tablet |
Unknown Cell Type 2 |
Adefin 10 mg film-coated tablet, 60 |
Unknown Cell Type 2 |
Adefin 10 mg film-coated tablet, 60, blister pack |
Unknown Cell Type 2 |
Adefin 20 mg film-coated tablet |
Unknown Cell Type 2 |
Adefin 20 mg film-coated tablet, 60 |
Unknown Cell Type 2 |
Adefin 20 mg film-coated tablet, 60, blister pack |
Unknown Cell Type 2 |
Adempas (riociguat 1 mg) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Adempas (riociguat 1 mg) film-coated tablet, 42 tablets (trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 1 mg) film-coated tablet, 42 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 1 mg) film-coated tablet, 84 tablets (trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 1 mg) film-coated tablet, 84 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 1.5 mg) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Adempas (riociguat 1.5 mg) film-coated tablet, 42 tablets (trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 1.5 mg) film-coated tablet, 42 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 1.5 mg) film-coated tablet, 84 tablets (trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 1.5 mg) film-coated tablet, 84 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 2 mg) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Adempas (riociguat 2 mg) film-coated tablet, 42 tablets (trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 2 mg) film-coated tablet, 42 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 2 mg) film-coated tablet, 84 tablets (trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 2 mg) film-coated tablet, 84 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 2.5 mg) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Adempas (riociguat 2.5 mg) film-coated tablet, 42 tablets (trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 2.5 mg) film-coated tablet, 42 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 2.5 mg) film-coated tablet, 84 tablets (trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 2.5 mg) film-coated tablet, 84 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 500 microgram) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Adempas (riociguat 500 microgram) film-coated tablet, 42 tablets (trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 500 microgram) film-coated tablet, 42 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 500 microgram) film-coated tablet, 84 tablets (trade product pack) |
Unknown Cell Type 2 |
Adempas (riociguat 500 microgram) film-coated tablet, 84 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Adempas 1 mg film-coated tablet |
Unknown Cell Type 2 |